Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $199.65M Marketcap

The problem is that its not yet a determined fact that PTSC will post 25-50% of their market cap in earnings this quarter. Most are treating this as a given....and if you've been with PTSC long enough you will know that nothing is a given. IMO this is why we see no volume, investors have been duped before and everyone is waiting to see the goods this time around before making a decision. If they show us the goods in the quarterly our shareprice should adjust.

Share
New Message
Please login to post a reply